Clincosm LogoSign in Get a demo

nafld

Showing 1 - 25 of 198
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Obesity, Liver Diseases, Liver Fibrosis Trial in Boston (ESG, GLP1-RA)

Not yet recruiting
  • Obesity
  • +16 more
  • Boston, Massachusetts
    Brigham and Women's Hospital
Nov 14, 2023

Subclinical Cardiac Dysfunction in Non-Alcoholic Fatty Liver

Not yet recruiting
  • NAFLD
  • Echocardiographic findings
  • (no location specified)
Nov 11, 2023

PCOS, NAFLD, NASH Trial in San Francisco, Durham

Recruiting
  • PCOS
  • +2 more
    • San Francisco, California
    • +1 more
    Nov 3, 2023

    Obesity, NAFLD Trial (Usual Care Control Group, Moderate-intensity Exercise Intervention, Vigorous-intensity Exercise

    Not yet recruiting
    • Obesity
    • NAFLD
    • Usual Care Control Group
    • +2 more
    • (no location specified)
    Nov 3, 2023

    Liver Disease Chronic, Fibrosis, Liver, Liver Steatoses Trial in London (Ultrasound based Elastography and fat quantification)

    Recruiting
    • Liver Disease Chronic
    • +6 more
    • Ultrasound based Elastography and fat quantification
    • London, United Kingdom
      Nuran Seneviratne
    Oct 26, 2023

    NAFLD Trial in Ahvaz (Soy isoflavone, Placebo)

    Completed
    • NAFLD
    • Soy isoflavone
    • Placebo
    • Ahvaz, Khuzestan, Iran, Islamic Republic of
      Asal Neshatbini Tehrani
    Oct 24, 2023

    Biomarkers in the Diagnosis and Prognosis of NAFLD

    Recruiting
    • NAFLD
    • +3 more
    • Plasma Test
    • +5 more
    • Trieste, Italy
      Silvia Palmisano
    Oct 18, 2023

    NAFLD Trial in Cairo (Control Test)

    Completed
    • NAFLD
    • Control Test
    • Cairo, Egypt
      Ain Shams University
    Oct 5, 2023

    Schizophrenia, Treatment-resistant Schizophrenia, Side Effect Trial (Aripiprazole, Paliperidone)

    Not yet recruiting
    • Schizophrenia
    • +6 more
    • (no location specified)
    Sep 27, 2023

    NAFLD, MASLD, Mild Inflammatory Context Trial (TOTUM-448)

    Not yet recruiting
    • NAFLD
    • +2 more
    • TOTUM-448
    • (no location specified)
    Sep 14, 2023

    Relation Between NAFLD and BM DENSITY

    Not yet recruiting
    • NAFLD
    • Osteoporosis
    • Fibroscan
    • (no location specified)
    Sep 14, 2023

    Non-alcoholic Fatty Liver Disease in Chronic Kidney Disease in

    Not yet recruiting
    • CKD
    • NAFLD
      • (no location specified)
      Aug 22, 2023

      Accurate Point of Care Liver Disease Diagnostics

      Recruiting
      • NAFLD
      • Nonalcoholic Fatty Liver
      • Liverscope® exam
      • +5 more
      • La Jolla, California
        University of California San Diego
      Aug 8, 2023

      Fatty Liver, NAFLD Trial (Coenzyme Q10 Forte® capsules)

      Not yet recruiting
      • Fatty Liver
      • NAFLD
      • Coenzyme Q10 Forte® capsules
      • (no location specified)
      Aug 8, 2023

      NAFLD, PCOS Trial in San Francisco (Bicalutamide 50 mg, Placebo)

      Not yet recruiting
      • NAFLD
      • PCOS
      • Bicalutamide 50 mg
      • Placebo
      • San Francisco, California
        University of California San Francisco
      Aug 4, 2023

      Risk Factors for Advanced Fibrosis Among FLD Patients

      Not yet recruiting
      • NAFLD
      • +2 more
      • Follow-up
      • (no location specified)
      Aug 1, 2023

      Defining Circadian Metabolism in Non-alcoholic Fatty Liver

      Recruiting
      • NAFLD
      • Lifestyle and weight loss advice
      • Oxford, United Kingdom
        University of Oxford
      Jul 18, 2023

      NAFLD, Diet Habit Trial (Diet intervention)

      Not yet recruiting
      • NAFLD
      • Diet Habit
      • Diet intervention
      • (no location specified)
      Jul 17, 2023

      Hepatic Steatosis, NAFLD, Adolescent Obesity Trial (Purity formulation by Amino Co, Placebo)

      Not yet recruiting
      • Hepatic Steatosis
      • +2 more
      • Purity formulation by Amino Co
      • Placebo
      • (no location specified)
      Jun 28, 2023

      NAFLD Trial (Placebo, 2 cap.LivPhcD/per day, 4 cap.LivPhcD/per day)

      Not yet recruiting
      • NAFLD
      • Placebo
      • +3 more
      • (no location specified)
      Jun 25, 2023

      Liver Steatoses, Liver Metastasis Colon Cancer, NAFLD Trial (Ketogenic Diet)

      Not yet recruiting
      • Liver Steatoses
      • +2 more
      • Ketogenic Diet
      • (no location specified)
      May 31, 2023

      NAFLD, Obesity, Type 2 Diabetes Trial (Saroglitazar)

      Not yet recruiting
      • NAFLD
      • +4 more
      • (no location specified)
      May 25, 2023

      Non-alcoholic Fatty Liver Disease, Fatty Liver, Nonalcoholic, NAFLD Trial (Efinopegdutide, Semaglutide, Placebo)

      Not yet recruiting
      • Non-alcoholic Fatty Liver Disease
      • +4 more
      • (no location specified)
      May 17, 2023

      RNPC Program in Obese and Overweight Patients (SCOOP-RNPC)

      Not yet recruiting
      • Overweight and Obesity
      • +6 more
      • Nutritional Psycho-Behavioral Reeducation Program
      • (no location specified)
      May 4, 2023

      NAFLD Trial (Caloric restriction intervention, No intervention)

      Not yet recruiting
      • NAFLD
      • Caloric restriction intervention
      • No intervention
      • (no location specified)
      Apr 24, 2023